Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Intervalo de año de publicación
1.
Arch Virol ; 169(7): 137, 2024 Jun 07.
Artículo en Inglés | MEDLINE | ID: mdl-38847873

RESUMEN

The present study focuses on the pathological and molecular characterization of African swine fever virus (ASFV) associated with an outbreak in wild boars in two national parks in southern India in 2022-2023. Significant mortality was observed among free-ranging wild boars at Bandipur National Park, Karnataka, and Mudumalai National Park, Tamil Nadu. Extensive combing operations were undertaken in both national parks, spanning an area of around 100 km2, originating from the reported epicenter, to estimate the mortality rate. Recovered carcasses were pathologically examined, and ASFV isolates was genetically characterized. Our findings suggested spillover infection of ASFV from nearby domestic pigs, and the virus was equally pathogenic in wild boars and domestic pigs. ASFV intrusion was reported in the Northeastern region of the country, which borders China and Myanmar, whereas the current outbreak is very distantly located, in southern India. Molecular data will help in tracing the spread of the virus in the country.


Asunto(s)
Virus de la Fiebre Porcina Africana , Fiebre Porcina Africana , Brotes de Enfermedades , Sus scrofa , Animales , Virus de la Fiebre Porcina Africana/genética , Virus de la Fiebre Porcina Africana/aislamiento & purificación , India/epidemiología , Porcinos , Fiebre Porcina Africana/virología , Fiebre Porcina Africana/epidemiología , Fiebre Porcina Africana/mortalidad , Sus scrofa/virología , Brotes de Enfermedades/veterinaria , Filogenia , Animales Salvajes/virología
2.
Virology ; 596: 110123, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38805805

RESUMEN

Lumpy Skin Disease (LSD), a poxvirus disease affecting cattle, emerged in India in 2019 and intensified in 2022, resulting in significant economic losses for dairy farmers. There was unusual shift in mortality and morbidity patterns during the second wave. A comprehensive genetic study conducted, analyzing samples from 2019 to 2022 revealed circulation of two distinct subclades (subclade 1.2a and 1.2b) in India, with the latter showing a different pattern in morbidity and mortality. Notably, the Ankyrin repeats gene-based analysis could differentiate animals with varying clinical scores. Genetic variations were significant, with unique deletions identified, including a 12-nucleotide deletion in the GPCR gene in virus isolates collected during 2022 outbreaks, not reported earlier in Indian LSDV strains. A crucial finding was a significant 95-nucleotide deletion in the Functional Resolution Sequence (FRS) repeats of LSDV genomes from 2022 outbreaks, absent in 2019 samples. These deletions may have influenced the virus's virulence in India.


Asunto(s)
Genoma Viral , Dermatosis Nodular Contagiosa , Virus de la Dermatosis Nodular Contagiosa , Filogenia , India/epidemiología , Animales , Dermatosis Nodular Contagiosa/virología , Dermatosis Nodular Contagiosa/epidemiología , Virus de la Dermatosis Nodular Contagiosa/genética , Virus de la Dermatosis Nodular Contagiosa/patogenicidad , Virus de la Dermatosis Nodular Contagiosa/aislamiento & purificación , Virulencia/genética , Bovinos , Brotes de Enfermedades/veterinaria , Variación Genética , Secuenciación Completa del Genoma
3.
J Neonatal Perinatal Med ; 17(1): 63-69, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38217614

RESUMEN

A circular shunt is a poor prognostic factor associated with Ebstein's anomaly. Targeting the constriction of the ductus arteriosus (DA) in order to limit or resolve the circular shunt, has been shown to improve fetal outcomes. Prenatal non-steroidal anti-inflammatory drugs (NSAIDs) have been known to constrict the DA. Recently, prenatal NSAIDs have been used for that purpose in the treatment of circular shunt. Limited research shows that it may be an effective treatment leading to improved fetal outcomes. In this article, we did an extensive review of literature to describe this therapy's effectiveness and outcomes. 82% of fetuses were able to achieve ductal constriction with prenatal NSAID therapy. For fetuses who achieved ductal constriction, fetal demise was less likely (6%) when compared to those who were unable to achieve the same (50%). Of all the fetuses with hydrops, 50% had resoluation of hydrops with prenatal NSAID treatment.


Asunto(s)
Conducto Arterioso Permeable , Conducto Arterial , Anomalía de Ebstein , Embarazo , Femenino , Humanos , Anomalía de Ebstein/tratamiento farmacológico , Antiinflamatorios no Esteroideos/uso terapéutico , Conducto Arterioso Permeable/tratamiento farmacológico , Conducto Arterial/diagnóstico por imagen , Edema
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA